Back to top
more

Envista (NVST)

(Delayed Data from NYSE)

$19.41 USD

19.41
3,595,288

+0.74 (3.96%)

Updated Sep 13, 2024 04:00 PM ET

After-Market: $19.40 -0.01 (-0.05%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value C Growth F Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 30% (75 out of 251)

Industry: Medical - Products

Better trading starts here.

Zacks News

Envista (NVST) Q2 Earnings and Revenues Top Estimates

Envista (NVST) delivered earnings and revenue surprises of 20.46% and 4.87%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

Canopy Growth (CGC) to Report in Q1 Earnings: What's in Store?

Continued robust product demand is expected to have significantly contributed to Canopy Growth's (CGC) top line in the fiscal first quarter.

Envista (NVST) Reports Next Week: Wall Street Expects Earnings Growth

Envista (NVST) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Kinjel Shah headshot

7 Low Price-to-Book Stocks to Add to Your Kitty

P/B ratio is emerging as a convenient tool to identify low-priced stocks that have high-growth prospects.

Medtronic (MDT) Introduces New Drug Coated Balloon Catheter

Medtronic's (MDT) newly-launched Prevail DCB demonstrates impressive safety and drug deliverability, utilizing a rapid absorption drug to treat patients with coronary artery disease.

Omnicell (OMCL) Faces Lingering Cost Woes, Fierce Competition

Omnicell's (OMCL) second-quarter 2021 guidance includes additional freight costs, given the ongoing global market conditions.

NuVasive (NUVA) Launches Modulus ALIF for Anterior Spine Surgery

The Modulus ALIF 3D-printed porous titanium implant is the latest addition to NuVasive's (NUVA) AMS portfolio for anterior lumbar interbody fusion procedures.

Medtronic's (MDT) Hugo RAS System Now Available at UC CHRISTUS

Recent integration of Medtronic's (MDT) Hugo RAS System at UC CHRISTUS is intended to support the teaching institution's new robotic surgery program.

Quest Diagnostics (DGX) Expands Testing Access With CLX Pact

Quest Diagnostics' (DGX) COVID-19 testing will be available through TrustAssure platform for international travelers and live event attendants.

NVST vs. PETQ: Which Stock Should Value Investors Buy Now?

NVST vs. PETQ: Which Stock Is the Better Value Option?

Cerner (CERN) Extends Partnership to Accelerate Digital Health

Cerner (CERN) expands its partnership with Baystate Health by launching a digital health platform to boost consumer-focused care.

Integra (IART) Releases Favorable PriMatrix Clinical Outcome

Integra's (IART) PriMatrix study data validates that one application of PriMatrix is needed to address hard-to-heal diabetic foot ulcers.

Thermo Fisher (TMO) Advances Customer Research With New Launch

Thermo Fisher's (TMO) new instrument enables high-resolution images of nanoparticles and beam-sensitive materials to be obtained from a commercially available desktop SEM.

Globus Medical (GMED) Marks New Milestone for ExcelsiusGPS

Globus Medical's (GMED) ExcelsiusGPS Robotic Navigation system reaches new surgical milestone for spinal procedures.

Thermo Fisher (TMO) to Meet Plasmid DNA Demand With New Facility

Thermo Fisher's (TMO) new facility will manufacture materials that are essential for production of plasmid-based therapies and vaccines.

National Vision (EYE) Banks on Partnerships Amid COVID-19 Woes

National Vision (EYE) is confident about its financial flexibility and liquidity helping it to navigate this pandemic.

Integra's (IART) SurgiMend Gets Innovative Technology Contract

Integra's (IART) SurgiMend Collagen Matrix is recognized as a product that can potentially bring improvement to the health care industry.

Fresenius Medical's (FMS) Xenios Gets NMPA Nod for ECMO System

Fresenius Medical (FMS) company receives expedited approval from NMPA permitting the Xenios AG's console and patient kits for ECMO therapy in China.

Here's Why You Should Retain Avanos (AVNS) Stock for Now

Investors continue to be optimistic about Avanos (AVNS) owing to its strong product line and focus on R&D.

Hologic (HOLX) COVID Test With Saliva Sample Gets CE Mark

Per Hologic (HOLX), saliva collection is noninvasive and painless. The availability of this alternative specimen type should facilitate screening at schools, workplaces and other settings.

Orthofix's (OFIX) SpinalStim Demonstrates Improved Fusion Rates

Orthofix's (OFIX) SpinalStim bone growth device demonstrates impressive fusion rates for patients recovering from lumbar fusion surgery.

Stryker (SYK) Unveils Tornier Shoulder Arthroplasty Portfolio

Stryker (SYK) introduces new Tornier shoulder arthroplasty portfolio enabling the company to strengthen its position in the shoulder market.

Here's Why You Should Retain Change Healthcare (CHNG) Stock

Change Healthcare (CHNG) continues to benefit from robust payment accuracy business. However, intense competition remains a woe.

Thermo Fisher's (TMO) New Pact Drives Sustainable Lab Practices

Thermo Fisher (TMO) expects to ACT label more than 1,200 additional SKUs to allow research, pharmaceutical and clinical laboratories to achieve their sustainability objectives.

QIAGEN (QGEN) Stock Falls on Downbeat Full-Year Guidance

According to QIAGEN (QGEN), stronger-than-expected growth trends were seen in non-COVID product groups in the second quarter of 2021.